Stockscreener 앱 받기
9.41
0.84%
-0.08
시간 외 거래:
9.74
0.33
+3.51%
전일 마감가:
$9.49
열려 있는:
$9.48
하루 거래량:
867.20K
Relative Volume:
0.64
시가총액:
$385.02M
수익:
$128.29M
순이익/손실:
$-30.69M
주가수익비율:
-11.48
EPS:
-0.82
순현금흐름:
$-27.17M
1주 성능:
+1.07%
1개월 성능:
+6.81%
6개월 성능:
-62.13%
1년 성능:
-82.43%
1일 변동 폭
$9.15
$9.58
1주일 범위
$8.835
$9.58
52주 변동 폭
$6.32
$55.57
Rxsight Inc Stock (RXST) Company Profile
명칭
Rxsight Inc
전화
949-521-7822
주소
100 COLUMBIA STREET, ALISO VIEJO
RXST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
9.41 | 388.29M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
136.04 | 234.21B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
97.83 | 145.55B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
376.83 | 144.45B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.08 | 122.61B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.41 | 43.77B | 5.69B | 1.41B | 577.90M | 6.95 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-07-09 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-09 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-07-09 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | 개시 | Piper Sandler | Neutral |
| 2025-04-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-04-04 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2025-04-03 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-12-20 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | 개시 | UBS | Buy |
| 2024-10-29 | 개시 | Jefferies | Buy |
| 2024-08-20 | 재확인 | Needham | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-05-07 | 재확인 | BTIG Research | Buy |
| 2023-12-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | 개시 | Stifel | Buy |
| 2023-12-04 | 개시 | Morgan Stanley | Overweight |
| 2023-04-13 | 개시 | Oppenheimer | Outperform |
| 2022-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | 개시 | Needham | Buy |
모두보기
Rxsight Inc 주식(RXST)의 최신 뉴스
RxSight, Inc. Class Action: Levi & Korsinsky Reminds RxSight, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - PR Newswire
RxSight, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before September 22, 2025 to Discuss Your RightsRXST - PR Newswire
RXST Deadline: RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - Eastern Progress
INVESTOR CLASS ACTION: RxSight, Inc. Investors are Reminded of the Ongoing Securities Fraud Lawsuit after Stock Plummeted 38% -- Contact BFA Law - GlobeNewswire Inc.
RxSight (RXST) Fell Due to Missed Expectations and Guidance Reduction - MSN
Deadline Soon: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - The Globe and Mail
RXSIGHT DEADLINEALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
Levi & Korsinsky Urges RxSight, Inc. (RXST) Shareholders to Act Before Lead Plaintiff Deadline September 22, 2025 - Barchart.com
RXST DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages RxSight, Inc. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class ActionRXST - MarketScreener
Shareholders that lost money on RxSight, Inc. (RXST) should - GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Morningstar
RxSight, Inc. Investors: Please contact the Portnoy Law - GlobeNewswire
RXSIGHT INVESTORS: New RxSight, Inc. Securities Class - GlobeNewswire
EXTENDED CLASS PERIOD: Investor Files Class Action Lawsuit Against RxSight, Inc. and Attorneys Announce Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - PR Newswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsRXST - MarketScreener
Goldman Sachs Group Inc. Buys 113,767 Shares of RxSight, Inc. $RXST - MarketBeat
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has B - GuruFocus
EXPANDED CLASS PERIOD: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Inquire About a Securities Fraud Class Action by September 22, 2025 - standard-journal.com
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Securities Lawsuit Alert: RxSight, Inc. (RXST)Contact Levi & Korsinsky Before September 22, 2025 - Barchart.com
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Silicon Valley - FinancialContent
Millennium Management LLC Decreases Position in RxSight, Inc. $RXST - MarketBeat
Royal Bank of Canada Trims Holdings in RxSight, Inc. $RXST - MarketBeat
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Newsfile
Lost Money on RxSight, Inc. (RXST)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire
EXTENDED CLASS PERIOD: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against RxSight, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - Business Wire
DEADLINE NEXT WEEK: Berger Montague Advises RxSight, Inc. (NASDAQ: RXST) Investors to Contact the Firm Before September 22, 2025 | Dow Theory Letters - FinancialContent
Investors SueWallSt as RxSight, Inc. Faces Securities Fraud Allegations - Nasdaq
Risk Recap: Can RxSight Inc sustain its profitabilityJuly 2025 Momentum & Risk Managed Investment Signals - khodrobank.com
RXST LEGAL NEWS: RxSight, Inc. Faces Securities Class - GlobeNewswire
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for InvestorsContact Levi & Korsinsky - FinancialContent
Investigation announced for Long-Term Investors in RxSight, Inc. (NASDAQ: RXST) over potential Wrongdoing - openPR.com
Rxsight Inc (RXST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.80%
1.23%
자본화:
|
볼륨(24시간):